SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009372
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:37
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20230331x10q.htm   iXBRL 10-Q 1126331
2 EX-31.1 armp-20230331xex31d1.htm EX-31.1 15462
3 EX-31.2 armp-20230331xex31d2.htm EX-31.2 15291
4 EX-32.1 armp-20230331xex32d1.htm EX-32.1 8016
5 EX-32.2 armp-20230331xex32d2.htm EX-32.2 8224
6 GRAPHIC armp-20230331x10q001.jpg GRAPHIC 41517
  Complete submission text file 0001558370-23-009372.txt   4391502

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20230331.xsd EX-101.SCH 33643
8 EX-101.CAL armp-20230331_cal.xml EX-101.CAL 31677
9 EX-101.DEF armp-20230331_def.xml EX-101.DEF 136503
10 EX-101.LAB armp-20230331_lab.xml EX-101.LAB 252523
11 EX-101.PRE armp-20230331_pre.xml EX-101.PRE 229018
53 EXTRACTED XBRL INSTANCE DOCUMENT armp-20230331x10q_htm.xml XML 534116
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 23910897
SIC: 2836 Biological Products, (No Diagnostic Substances)